1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide

scientific article published on 01 August 1994

1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0039-128X(94)90064-7
P698PubMed publication ID7985212

P2093author name stringF Labrie
S M Singh
P Dionne
P433issue8
P304page(s)493-497
P577publication date1994-08-01
P1433published inSteroidsQ15716675
P1476title1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide
P478volume59

Reverse relations

cites work (P2860)
Q74502716A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1
Q54308516A stereoselective synthesis of 7 alpha-(3-carboxypropyl) estradiol from a noncontrolled substance.
Q40888023N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity